Matt Norton, VP of Marketing & Commercial Development will be presenting at this year's DTx East:
Co-creating, partnering, and licensing DTx: The trade-offs for pharma on responsibilities, risk, and retaining commercial control:
- What are the trade-offs and potential downsides
- What is the right mix to build success: responsibilities, risk, and commercial control
- Our experience and learnings from the co-creation of DTx
Contact us to meet during the conference and learn more about how we partner with pharma to create digital health solutions that improve the lives of people with acute and chronic conditions.